Generate Biomedicines, Inc. (GENB)

15.18 -0.81 (-5.07%) USD  |  NASDAQ  |  Sep 25, 11:23
More

Generate Biomedicines Cash and Short Term Investments (Quarterly) : 457.42M for June 30, 2026

Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for GENB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2026. Start Trial.
Date Value
June 30, 2026 457.42M
Date Value
March 31, 2026 516.64M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Twist Bioscience Corp. 166.84M
Intellia Therapeutics, Inc. 437.76M
Prime Medicine, Inc. 95.07M
Moderna, Inc. 5.138B
Beam Therapeutics, Inc. 1.153B